Clinical Trial Update: A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ARV-471 to Anastrozole in postmenopausal women with breast cancer before surgery has completed and results have been posted. The study a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARV-471
• Anastrozole (Anastrozole)

Snippet

Sponsor: Arvinas Inc. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-08-29